We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

1 results found

Article

Orrick, Herrington & Sutcliffe LLP | USA | 13 Jun 2013

Myriad: the court has spoken - isolated DNA is not patent-eligible subject matter

Today, the U.S. Supreme Court issued its anxiously awaited decision in Association for Molecular Pathology et al. v. Myriad Genetics, Inc., No

Previous page 1 Next page